Viewing StudyNCT00004862



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004862
Status: COMPLETED
Last Update Posted: 2013-02-01
First Post: 2000-03-07

Brief Title: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
recurrent adult acute lymphoblastic leukemia View
recurrent adult acute myeloid leukemia View